Pages that link to "Q34198445"
Jump to navigation
Jump to search
The following pages link to Immune response following intraocular delivery of recombinant viral vectors (Q34198445):
Displaying 50 items.
- Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid (Q26774462) (← links)
- An empty E1, E3, E4 adenovirus vector protects photoreceptors from light-induced degeneration (Q33574612) (← links)
- Comparative study of the transfection efficiency of commonly used viral vectors in rhesus monkey (Macaca mulatta) brains (Q33577391) (← links)
- Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice. (Q33739804) (← links)
- Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modifications (Q34215308) (← links)
- Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer (Q34325086) (← links)
- Vector platforms for gene therapy of inherited retinopathies. (Q34561531) (← links)
- Lentiviral mediated gene delivery to the anterior chamber of rodent eyes (Q35153670) (← links)
- Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho(-/-) mouse (Q35651062) (← links)
- Gene therapy for proliferative ocular diseases (Q35842653) (← links)
- An HNF1α-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells (Q35925605) (← links)
- Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid (Q35957338) (← links)
- Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients (Q36147481) (← links)
- The liberation of CD44 intracellular domain modulates adenoviral vector transgene expression (Q36294870) (← links)
- Retinal Gene Therapy: Current Progress and Future Prospects (Q36306263) (← links)
- Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth (Q36594271) (← links)
- Let There Be Light: Gene and Cell Therapy for Blindness (Q36654534) (← links)
- Rescue of sight by gene therapy - closer than it may appear (Q36951825) (← links)
- Adenoviral gene transfer of bioactive TGFbeta1 to the rodent eye as a novel model for anterior subcapsular cataract (Q37109133) (← links)
- Barriers for retinal gene therapy: separating fact from fiction (Q37195446) (← links)
- Effects of Acute Low-Dose Exposure to the Chlorinated Flame Retardant Dechlorane 602 and Th1 and Th2 Immune Responses in Adult Male Mice (Q37230329) (← links)
- Primate neural retina upregulates IL-6 and IL-10 in response to a herpes simplex vector suggesting the presence of a pro-/anti-inflammatory axis (Q37331180) (← links)
- Advances in gene therapy technologies to treat retinitis pigmentosa. (Q37427526) (← links)
- Correction of Monogenic and Common Retinal Disorders with Gene Therapy (Q37676230) (← links)
- Novel gene therapeutic strategies for the induction of tolerance in cornea transplantation (Q37755334) (← links)
- Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies (Q37784661) (← links)
- Applications of nanoparticles in ophthalmology (Q37786424) (← links)
- Neovascular age-related macular degeneration: opportunities for development of first-in-class biopharmaceuticals (Q37882685) (← links)
- Lentivirus delivery by adsorption to tissue engineering scaffolds (Q38349634) (← links)
- Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward (Q38732888) (← links)
- AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray (Q38814333) (← links)
- Novel AAV serotypes for improved ocular gene transfer (Q39708886) (← links)
- Prospects for genetic modulation of corneal graft survival (Q40016839) (← links)
- Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina. (Q40057668) (← links)
- Gene Manipulation Strategies to Identify Molecular Regulators of Axon Regeneration in the Central Nervous System (Q40077177) (← links)
- CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10. (Q40369908) (← links)
- Gene expression changes induced by a recombinant E1-/E3- adenovirus type 5 vector in human mammary epithelial cells. (Q40396580) (← links)
- Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses (Q40413612) (← links)
- Rapid, widespread transduction of the murine myocardium using self-complementary Adeno-associated virus (Q41909668) (← links)
- Preservation of cardiac function in left ventricle cardiac hypertrophy using an AAV vector which provides VEGF-A expression in response to p53. (Q42176122) (← links)
- In vitro adenovirus mediated gene transfer to the human cornea (Q42907140) (← links)
- Virology and immunology of gene therapy, or virology and immunology of high MOI infection with defective viruses (Q45862358) (← links)
- Lentivirus-mediated gene transfer to the rat, ovine and human cornea (Q45866024) (← links)
- Immunity to CRISPR Cas9 and Cas12a therapeutics (Q45873745) (← links)
- Adenoviral capsid modulates secretory compartment organization and function in acinar epithelial cells from rabbit lacrimal gland. (Q45873838) (← links)
- Distinctive gene transduction efficiencies of commonly used viral vectors in the retina (Q45874652) (← links)
- Viral and nonviral gene therapy for treatment of retinal diseases (Q46597216) (← links)
- Gene Therapy for Neuropathic Pain through siRNA-IRF5 Gene Delivery with Homing Peptides to Microglia (Q56889324) (← links)
- Viral Delivery Systems for CRISPR (Q61806550) (← links)
- Toll-like receptors 4, 5, 6 and 7 are constitutively expressed in non-human primate retinal neurons (Q89319798) (← links)